Pretorius Rachelle A, Avraam Demetris, Guxens Mònica, Julvez Jordi, Harris Jennifer R, Nader Johanna Thorbjornsrud, Cadman Tim, Elhakeem Ahmed, Strandberg-Larsen Katrine, Marroun Hanan El, Defina Serena, Yang Tiffany C, McEachan Rosie, Wright John, Ibarluzea Jesús, Santa-Marina Loreto, Delgado Juana Mari, Rebagliato Marisa, Charles Marie-Aline, Vainqueur Chloe, Maritano Silvia, Zugna Daniela, Yuan Wen Lun, Heude Barbara, Huang Rae-Chi
Nutrition & Health Innovation Research Institute, Edith Cowan University, Perth, WA, Australia.
Medical School, The University of Western Australia, Crawly, Perth, WA, Australia.
BMC Pediatr. 2025 Jan 30;25(1):76. doi: 10.1186/s12887-024-05365-y.
Growing evidence shows that dysregulated metabolic intrauterine environments can affect offspring's neurodevelopment and behaviour. However, the results of individual cohort studies have been inconsistent. We aimed to investigate the association between maternal diabetes before pregnancy and gestational diabetes mellitus (GDM) with neurodevelopmental, cognitive and behavioural outcomes in children.
Harmonised data from > 200 000 mother-child pairs across ten birth cohorts in Europe and Australia were available. Mother-child pairs were included for analysis to determine whether GDM was recorded (yes or no) and whether at least one neurodevelopmental, cognitive and behavioural outcome was available in children aged 3 to 13 years. Confounder-adjusted regression models were used to estimate associations between maternal diabetes and child outcomes using two-stage individual participant data (IPD) meta-analysis. Model 1 included a crude estimate. The full adjustment model (model 2) included adjustment for child sex, maternal age, pre-pregnancy BMI, pregnancy weight gain, maternal smoking during pregnancy, plurality, parity and maternal education.
Children (aged 7-10 years) born to mothers with GDM had higher attention-deficient hyperactive disorder (ADHD) symptoms compared to non-exposed controls (model 2, regression coefficient (β) 3.67 (95% CI 1.13, 6.20), P = 0.001). Moreover, children (aged 4-6 years) born to mothers with GDM exhibited more externalising problems than those born to mothers without GDM (model 2, β 2.77 (95% CI 0.52, 5.02), P = 0.01). A pre-existing maternal history of type 1 and type 2 diabetes mellitus was associated with ADHD symptoms at 4-6 years (model 1, β 8.82 (95% CI 2.21, 15.45, P = 0.009) and β 7.90 (95% CI 0.82, 14.98, P = 0.02), respectively). The association was no longer apparent in further adjustments.
This study found that children between 4 - 6 and 7-10 years of age born to mothers with GDM have a greater likelihood of developing externalising problems and ADHD symptoms, respectively. Externalising problems often co-exist with ADHD symptoms and precede formal ADHD diagnosis. Overall, this large-scale multi-cohort study suggested that a dysregulated metabolic environment during pregnancy may contribute to ADHD symptoms and externalising problems in young children.
越来越多的证据表明,代谢失调的子宫内环境会影响后代的神经发育和行为。然而,个别队列研究的结果并不一致。我们旨在调查孕前糖尿病和妊娠期糖尿病(GDM)与儿童神经发育、认知和行为结局之间的关联。
可获取来自欧洲和澳大利亚10个出生队列中超过20万对母婴的协调数据。纳入母婴对进行分析,以确定是否记录了GDM(是或否),以及3至13岁儿童是否至少有一项神经发育、认知和行为结局。使用两阶段个体参与者数据(IPD)荟萃分析,通过混杂因素调整回归模型来估计母亲糖尿病与儿童结局之间的关联。模型1包括粗略估计。完全调整模型(模型2)包括对儿童性别、母亲年龄、孕前BMI、孕期体重增加、孕期母亲吸烟、多胎、产次和母亲教育程度的调整。
与未暴露的对照组相比,患有GDM的母亲所生儿童(7至10岁)的注意力缺陷多动障碍(ADHD)症状更严重(模型2,回归系数(β)3.67(95%CI 1.13,6.20),P = 0.001)。此外,患有GDM的母亲所生儿童(4至6岁)比未患GDM的母亲所生儿童表现出更多的外化问题(模型2,β 2.77(95%CI 0.52,5.02),P = 0.01)。母亲有1型和2型糖尿病的既往史与4至6岁时的ADHD症状相关(模型1,β分别为8.82(95%CI 2.21,15.45,P = 0.009)和β 7.90(95%CI 0.82,14.98,P = 0.02))。在进一步调整后,这种关联不再明显。
本研究发现,患有GDM的母亲所生的4至6岁和7至10岁儿童分别更有可能出现外化问题和ADHD症状。外化问题通常与ADHD症状同时存在,并先于正式的ADHD诊断。总体而言,这项大规模多队列研究表明,孕期代谢环境失调可能导致幼儿出现ADHD症状和外化问题。